The Patent Linkage Program of the U.S Drug Market Review
碩士 === 國立雲林科技大學 === 科技法律研究所碩士班 === 101 === The patent linkage program of the United States, means that the marketing approval of generic drugs are 「linked」to the judgment of whether the generics infringe a valid patent held by a brand-name pharmaceutical company on the same type of drugs or not. In...
Main Authors: | Chiu-jung Huang, 黃秋蓉 |
---|---|
Other Authors: | Chin-Chieh Yang |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/98198773946196491541 |
Similar Items
-
The Impact of US Patent Linkage on Marketing of Generic Drugs.
by: Yang Jhen-Hong, et al.
Published: (2015) -
Pre-Approval Patent Resolution Process of Drug Product- Lessons From U.S. Patent Linkage
by: Wu, Tung-Che, et al.
Published: (2015) -
Economic Links and Stock Return Linkages in the U.S. Market
by: Shih-Ting Huang, et al. -
The Interaction between Patent & Copyright Misuse Doctrine and Competition Law: Lessons from the U.S.
by: Chiu-Lien Huang, et al.
Published: (2013) -
U.S. Antitrust Law Market Definition in Patent Licensing Cases
by: Ching-Yuan Huang, et al.
Published: (2006)